In the present study, subgroup analysis for median OS in Stage IV oral malignant cases indicated that treatment–response cases tended to prolong survival when compared to non-response cases, but the difference did not reach statistical significance.
← all excerpts
A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs.
1
—
—